Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • icahn_seq
    Junior Member
    • Feb 2018
    • 2

    #1

    SureSelect XT Probes

    Hi everyone,

    I was wondering if anyone else had tested their SureSelect XT (< 3.0 Mb bait territory) bait library concentration?

    I recently used the Qubit to test mine and it was ~ 50 ng/uL. I'm a little confused because according to the original Gnirke et al Nat. Biotech 2009 papers hybridization was done with equal mass of pond library and bait library (500 ng each). Going by the XT protocol wouldn't this mean it would be only 100 ng bait to 750 ng library?
  • Gopo
    Member
    • Nov 2013
    • 41

    #2
    As far as I know, Agilent will not confirm or deny any of their bait library concentrations.

    Comment

    • icahn_seq
      Junior Member
      • Feb 2018
      • 2

      #3
      Originally posted by Gopo View Post
      As far as I know, Agilent will not confirm or deny any of their bait library concentrations.
      Oh, I see. Thanks for your input! I thought about it a little more, and maybe I should be thinking of the ratio in terms of ng bait to ng of target DNA and not the mass of the entire genomic library. Ex) 3 mb target space ~1/1000 of genome therefore there would be 0.75 ng of target dna in the 750 ng pond.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Working...